Works matching IS 00912700 AND DT 2023 AND VI 63 AND IP 11


Results: 14
    1
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Population Pharmacokinetics and Exposure–Response Analysis of Tremelimumab 300 mg Single Dose Combined with Durvalumab 1500 mg Q4W (STRIDE) in Patients with Unresectable Hepatocellular Carcinoma.

    Published in:
    Journal of Clinical Pharmacology, 2023, v. 63, n. 11, p. 1221, doi. 10.1002/jcph.2288
    By:
    • Lim, KyoungSoo;
    • Abegesah, Aburough;
    • Fan, Chunling;
    • He, Jimmy Zhijian;
    • Song, Xuyang;
    • Chen, Cecil;
    • Negro, Alejandra;
    • Makowsky, Mallory;
    • Gupta, Charu;
    • Ren, Song;
    • Phipps, Alex;
    • Gibbs, Megan;
    • Zhou, Diansong
    Publication type:
    Article
    14

    Issue Information.

    Published in:
    Journal of Clinical Pharmacology, 2023, v. 63, n. 11, p. 1175, doi. 10.1002/jcph.1905
    Publication type:
    Article